PCR controls are designed to make failures interpretable. A control is useful only when its composition, location in the workflow, expected result, acceptance criteria, and follow-up action are defined. Adding more controls without a clear purpose can increase complexity while leaving important process steps unchallenged.
No-template and reagent negative controls
A no-template control contains amplification reagents without target nucleic acid. It can reveal contamination or nonspecific background introduced during reaction setup. It does not pass through sample collection or extraction, so it cannot demonstrate that those upstream steps were contamination-free.
Negative sample and extraction controls
A negative sample control contains a target-negative matrix or suitable surrogate and may be processed through extraction. An extraction blank can identify contamination introduced by extraction reagents, equipment, or handling. The appropriate negative control depends on the workflow and the failure that must be detected.
Positive amplification controls
A positive amplification control contains target material and demonstrates that amplification and detection can occur. Its concentration should challenge the system meaningfully; an extremely strong control may remain positive even when reagent performance has deteriorated. Material design should also reduce contamination risk.
Positive process controls
A process control enters before extraction and can challenge more of the complete workflow. Its matrix and form should be sufficiently representative for the intended purpose. It may not be identical to a patient sample, so the technical file should state what it does and does not control.
Internal amplification controls
An internal control is amplified in the same reaction as the target and may help identify inhibition, extraction failure, reagent failure, or sample inadequacy depending on where it is introduced and how it is designed. It must not materially compete with the target, particularly near the assay detection boundary.
RT-qPCR and multiplex considerations
RNA workflows may need controls that challenge reverse transcription as well as amplification. Multiplex controls consume primers, probes, enzyme capacity, and optical channels. Control concentration and channel assignment should be balanced with low-level target detection rather than optimized separately.
Configure controls for repeat supply
Control materials require specifications for identity, concentration, matrix, homogeneity, container, labeling, storage, stability, and expected result. Evaluation lots should confirm that supplied controls behave with the assay and do not introduce unexpected contamination or competition.
Set control concentrations around the decisions they support
A very strong positive control confirms that amplification can occur but may not reveal a meaningful loss of low-level performance. An internal control that is too concentrated can compete with the target, while one that is too weak may fail for unrelated stochastic reasons. Select concentrations that challenge the relevant failure mode and define expected ranges before reviewing the result. The correct level is assay- and workflow-specific.
Document invalid-result logic before transfer
The method should state how target and control combinations are interpreted, which control failures invalidate a run or sample, and when repeat testing or investigation is triggered. These rules should align with the control design and the receiving laboratory's responsibilities. Leaving invalid-result logic until after unexpected data appear invites inconsistent decisions and makes reagent, extraction, and instrument problems harder to distinguish.